Pseudoexfoliation Glaucoma

Overview

Pseudoexfoliation syndrome (PEX, also called exfoliation syndrome, XFS) is a systemic elastotic disorder characterized by the production and deposition of abnormal fibrillar material in the anterior segment and other tissues throughout the body. When this material accumulates in the trabecular meshwork and obstructs aqueous outflow, causing glaucomatous optic neuropathy, the condition is termed pseudoexfoliation glaucoma (PXG) — the most recognizable and common form of secondary open-angle glaucoma associated with a high risk of blindness.³

Epidemiology & Risk Factors

PEX prevalence increases with age and varies substantially by population and geography, with notably higher rates reported in Scandinavian populations. In a hospital-based cohort of patients undergoing cataract surgery, PEX was identified in 10.7% of eyes.² Patients with PEX have a roughly ten-fold higher risk of developing glaucoma than the general population.¹ There is growing evidence of systemic associations between PEX and cardiovascular disease, cerebrovascular disease, Alzheimer's disease, hearing loss, and elevated plasma homocysteine, suggesting PEX may reflect a broader systemic connective tissue/elastotic process rather than a purely ocular condition.¹

Pathophysiology

The precise pathogenesis of PEX remains incompletely understood despite decades of genetic and molecular research (notably implicating the LOXL1 gene, though this alone does not fully explain disease penetrance or severity).³ Emerging areas of investigation beyond the primary genetic associations include epigenetic factors (microRNA dysregulation), disordered autophagy, mitochondrial dysfunction, and a compromised blood-aqueous barrier, reflecting oxidative stress as a common downstream theme.³ Regardless of the precise upstream trigger, abnormal fibrillar (pseudoexfoliative) material progressively deposits in the trabecular meshwork, increasing outflow resistance; material deposited on the zonules also causes progressive zonular weakness, which has major implications for cataract surgery planning.

Clinical Presentation

Many patients are asymptomatic in early PEX, identified incidentally on slit-lamp exam via characteristic material on the anterior lens capsule. As glaucoma develops, presentation resembles other open-angle glaucomas (asymptomatic until relatively advanced field loss), though some patients present with markedly elevated IOP or an acute pressure spike, particularly after pupillary dilation, which can liberate additional pigment and exfoliative material into the anterior chamber.

Exam Findings

• Classic "bull's-eye" pattern of pseudoexfoliative material on the anterior lens capsule: a central disc, clear zone, and peripheral granular zone, best seen after pupillary dilation
• Pseudoexfoliative material also visible on the pupillary margin, ciliary processes, zonules, and corneal endothelium
• Patchy, often asymmetric pigmentation of the trabecular meshwork on gonioscopy (distinct from the dense, homogeneous pattern of pigmentary glaucoma)
• Higher maximum and mean IOP at diagnosis, and wider IOP fluctuation, compared with primary open-angle glaucoma¹
• Poorly dilating pupil (from iris sphincter atrophy/rigidity) and phacodonesis or lens subluxation in advanced disease from zonular weakness¹
• Frequently asymmetric or unilateral presentation, at least initially, though it typically becomes bilateral over time

Differential Diagnosis

• Pigmentary glaucoma (different material pattern, different typical age/demographic, though overlap syndrome can occur)
• Primary open-angle glaucoma without exfoliative material
• Other causes of lens subluxation/zonular weakness (trauma, Marfan syndrome, homocystinuria) in patients presenting primarily with lens instability
• Uveitic glaucoma, which can also show pigment/debris on anterior segment structures

Management

Diagnosis is made by identifying pseudoexfoliative material on the anterior lens capsule and other anterior segment structures, generally best visualized after pupillary dilation, combined with standard glaucomatous optic nerve/visual field assessment. PXG classically responds poorly to medical therapy, and surgical intervention is required more often and earlier than in primary open-angle glaucoma.³ Indications for surgery are markedly more common in PXG than POAG.¹

Cataract surgery in PEX patients requires specific precautions given the associated zonular weakness and poor pupillary dilation: eyes with PEX have significantly higher rates of intraoperative complications risk related to these factors, harder nuclear cataracts on average, and though one hospital-based series found no statistically significant difference in intraoperative/postoperative complication rates between PEX and non-PEX eyes, this should be interpreted cautiously given the known biomechanical risk factors, and surgeons should still prepare specific tools and techniques (e.g., pupil expansion devices, capsular tension rings) in anticipation.²

Complications

• Higher risk of vision loss compared with primary open-angle glaucoma, from more severe and fluctuating IOP elevation¹
• Zonular weakness leading to phacodonesis, lens subluxation, and increased intraoperative complication risk during cataract surgery
• Acute IOP spikes, particularly after pupillary dilation
• Progression to bilateral disease over time, even if initially unilateral/asymmetric
• Poorer visual outcomes in the immediate postoperative period after cataract surgery compared with non-PEX eyes, though outcomes tend to converge by one month²

Clinical Pearls

• PXG is the most common identifiable cause of secondary open-angle glaucoma worldwide and carries a roughly ten-fold higher glaucoma risk than the general population once PEX is present¹
• The classic "bull's-eye" lens capsule pattern (central disc, clear zone, peripheral granular zone) is best seen after pupillary dilation — don't skip dilated exam in at-risk patients
• Always anticipate zonular weakness and poor dilation when planning cataract surgery in PEX patients, and have pupil expansion devices/capsular tension rings available
• PXG tends to respond poorly to medical therapy alone and often requires earlier surgical intervention than POAG³
• Consider systemic associations (cardiovascular, cerebrovascular, Alzheimer's disease) when PEX is identified, given growing evidence of a broader connective tissue/elastotic process¹

Common Pitfalls

• Missing PEX material because the pupil was not dilated during examination
• Underestimating IOP fluctuation risk in PXG by relying on a single office IOP measurement
• Failing to anticipate zonular weakness during cataract surgery planning, increasing risk of intraoperative complications
• Treating PXG medically for a prolonged period when surgical intervention would be more appropriate given its typically poorer medical response
• Confusing the patchy, asymmetric trabecular pigmentation of PXG with the dense, homogeneous 360-degree pigmentation more typical of pigmentary glaucoma